http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103191149-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5db336828b57d9e11fec4566859abcf2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42 |
| filingDate | 2012-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f57b7cef27858a709c8d252e921a7870 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e17dc9e39f209bc16fbdb690cb57051d |
| publicationDate | 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103191149-A |
| titleOfInvention | Medicinal composition for treating osteoporosis, and preparation thereof |
| abstract | The invention discloses a medicinal composition for treating osteoporosis, and a preparation thereof. The preparation contains a medicinal composition having an effective treatment amount and dissolved in a pharmaceutically acceptable carrier, the medicinal composition includes medicinal active molecules-containing K, Mg, Ca and Na combination groups and pharmaceutically acceptable biological trace element combination groups, and the skin penetration rate of the medicinal composition is not lower than the skin penetration rate of a reference solution obtain by dissolving the medicinal composition in a 80% medical aqueous solution. The preparation of the medicinal composition for treating osteoporosis has the advantages of substantial improvement of the osteoporosis treatment effect, reduction of the health danger and side effects associated with the taking of common osteoporosis treating medicines (parathyroid hormone, thyroid hormone, female hormones and calcium supplements), and good absorbent, safety and usability through a transdermal delivery mode. |
| priorityDate | 2012-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.